
<h1>NCLT Directs Hearing for Composite Scheme of Arrangement Involving Laurus Labs Subsidiaries</h1>
The National Company Law Tribunal (NCLT), Amravati Special Branch, has issued an order concerning a Composite Scheme of Arrangement involving subsidiaries of Laurus Labs Limited. The order was pronounced on July 24, 2026, and sets the next date for the consideration of the scheme.
The Petitioners, which include Laurus Synthesis Private Limited (LSPL), Sriam Labs Private Limited, and Laurus Labs Limited, are undertaking a complex corporate restructuring as part of the Scheme. All three entities are wholly-owned subsidiaries of Laurus Labs Limited.
The Composite Scheme involves two major components. Firstly, it addresses the demerger of Laurus Synthesis Private Limited (LSPL), where Unit-1 of LSPL is being transferred to Sriam Labs Private Limited. Secondly, the scheme includes the amalgamation of the remaining business undertakings of LSPL with Laurus Labs Limited (referred to as the Transferee Company).
Following the NCLT order, the Petitioners have been directed to serve a notice of the hearing of the Petition in Form No. CAA-3 to relevant authorities and other stakeholders.
The Tribunal further set the next date of hearing for September 10, 2026, specifically for the consideration of this Composite Scheme of Arrangement.
LAURUSLABS Stock Price Movement
On Friday, shares of Laurus Labs Limited surged higher in the closed market, settling at ₹1601.20 after closing up 2.60%. The robust equity move was underscored by strong trading interest and saw the stock approach its 52-week high levels while clearing a volume exceeding 2.65 million shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.